AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol (October 8, 2008). doi:10.1152/ajpregu.00850.2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
295/6/R1866    most recent
00850.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Bivol, L. M.
Right arrow Articles by Iversen, B. M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bivol, L. M.
Right arrow Articles by Iversen, B. M.
Submitted on November 27, 2007
Accepted on October 1, 2008

Tetradecylthioacetic acid down-regulates cyclooxygenase 2 in the renal cortex of two-kidney, one-clip hypertensive rats

Liliana Monica Bivol1, Michael Hultstrom2, Oddrun A. Gudbrandsen3, Rolf Kristian Berge1, and Bjarne Magnus Iversen1*

1 Institute of Medicine, University of Bergen, Bergen, Norway
2 Renal Research Group, Institute of Medicine, University of Bergen, Bergen, Norway
3 Lipid Research Group, Institute of Medicine, University of Bergen, Bergen, Norway

* To whom correspondence should be addressed. E-mail: bjarne.iversen{at}med.uib.no.

The effect of tetradecylthioacetic acid (TTA) on the cyclooxygenase (COX) system was investigated in 2K1C hypertensive rats. The systolic blood pressure (BP) was increased 6 weeks after clipping to 183 ± 4 mmHg vs.127 ± 3 mmHg in TTA treated 2K1C rats. The COX1 protein expression was not affected either by the 2K1C procedure or by TTA treatment. COX2 expression was up-regulated in both kidneys, but to a greater extent in the clipped kidney. COX2 activity was 16±3% in control and 38 ±2% (p<0.001) in the clipped kidney, and COX2 protein expression was 1.3 ±0.04 in control and 1.6 ± 0.12 in the clipped kidney (p=0.006). TTA reduced COX2 activity to control levels. Subcutaneously infusion of a COX2 inhibitor did not reduce BP. Peroxisome proliferator-activated receptors (PPARs) were detected in both kidneys and PPAR delta was up-regulated in the non-clipped kidney after TTA treatment. Prostaglandin E2 (PGE2) in renal cortex was increased in 2K1C (31 ±0.3 in the clipped and 28 ±0.2 pg·ml-1 non-clipped kidney, p<0.001 compared to control). TTA lowered the PGE2 to control level. Renal blood flow (RBF) response to exogenous angiotensin II (ANG II) injected into the control and non-clipped kidney was exaggerated after indomethacin treatment, but unchanged in the non-clipped kidney of 2K1C TTA group. Overall, these results indicate that after 6 weeks of treatment, TTA down-regulated COX2 activity, which have potentially important effects on the regulation of renal hemodynamics but does not explain TTAs ability to lower blood pressure







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.